James W. Green - Dec 29, 2023 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Role
Chief Executive Officer, Director
Signature
/s/ David Sirois, by power of attorney
Stock symbol
HBIO
Transactions as of
Dec 29, 2023
Transactions value $
-$1,129,824
Form type
4
Date filed
1/3/2024, 05:18 PM
Previous filing
Aug 21, 2023
Next filing
Mar 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HBIO Common Stock Tax liability -$129K -24.2K -0.84% $5.35 2.84M Dec 29, 2023 Direct F1
transaction HBIO Common Stock Tax liability -$154K -28.8K -1.01% $5.35 2.81M Dec 29, 2023 Direct F1
transaction HBIO Common Stock Tax liability -$124K -23.2K -0.83% $5.35 2.79M Dec 29, 2023 Direct F1
transaction HBIO Common Stock Tax liability -$279K -52.2K -1.87% $5.35 2.73M Dec 29, 2023 Direct F1
transaction HBIO Common Stock Tax liability -$443K -82.8K -3.03% $5.35 2.65M Dec 31, 2023 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit awards previously granted to the Reporting Person that vested on December 29, 2023.
F2 The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person that vested on December 31, 2023.
F3 Includes (a) 235,427 restricted stock units that will vest in two equal installments on December 29, 2024 and 2025, (b) 52,346 restricted stock units that will vest on December 29, 2024, (c) 484,975 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (d) 1,878,749 shares of common stock beneficially owned by the Reporting Person.